Updated on 11 September 2026
Expertise for HORIZON-MISS-2027-02-CANCER-04
Assoc. Prof. at Lithuanian university of health sciences
Kaunas, Lithuania
About
LSMU and Hospital of LSMU Kauno klinikos have substantial experience in comprehensive cancer care, patient management, and clinical outcomes assessment. The institution is interested in evaluating healthcare interventions that improve access, quality, effectiveness, and patient-centred cancer services. Its expertise spans oncology, public health, epidemiology, and healthcare management, enabling multidisciplinary approaches to health systems research. LSMU can contribute evidence from clinical practice and real-world healthcare settings to support outcome evaluation and policy development. Participation in European consortia would help advance equitable cancer care and identify sustainable approaches that maximize value for patients and healthcare systems.
Topic
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Expertise in HORIZON-MISS-2027-02-CANCER-04
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Rita Kupcinskaite
Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences
Kaunas, Lithuania
Project cooperation
Expertise for HORIZON-MISS-2027-02-CANCER-01
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
Rita Kupcinskaite
Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences
Kaunas, Lithuania
Project cooperation
Expertise for HORIZON-MISS-2027-02-CANCER-03
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Erika Korobeinikova
Assoc. Prof. at Lithuanian university of health sciences
Kaunas, Lithuania